A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients
Clinical trial NCT01628965 · COMPLETED
Trial details
- NCT number
- NCT01628965
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2010-10-01
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.